Physician profile
Matthew E Bohm
NPI 1912966979
$912.16
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $72.17 · 2024: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $172.94 | 2024 | Tremfya, Stelara |
| Allergan, INC. | $161.97 | 2019 | |
| Lilly USA, LLC | $80.74 | 2019 | |
| Novo Nordisk INC | $76.40 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.25 | 2019-2020 | |
| Amgen INC. | $54.87 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.74 | 2019 | |
| Astellas Pharma US INC | $38.06 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $36.38 | 2019 | |
| Abbvie INC. | $24.60 | 2019 | |
| Hologic Sales and Service, LLC | $22.18 | 2024 | Thinprep 2000 Processor, Aptima |
| Avanir Pharmaceuticals, INC. | $16.01 | 2019 | |
| Ironshore Pharmaceuticals INC. | $15.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.43 | 2019 | |
| Tris Pharma INC | $13.23 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.62 | 2019 | |
| Mylan Specialty L.P. | $12.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.86 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.36 | 2019 | |
| Glaxosmithkline, LLC. | $11.11 | 2020 | |
| Shire North American Group INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bohm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.